Assoc Prof Darren Kelly: Ledger

Stories naming Assoc Prof Darren Kelly. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Assoc Prof	University of Melbourne	bionity.com

Series A $3m

Fibrotech Therapeutics receives investment funding from Brandon Capital Partners, MRCF and Uniseed to develop fibrosis drugs

Fibrotech Therapeutics raised $3 million in Series A backing from Brandon Capital-managed funds MRCF, BBF1 IIF and Uniseed to advance fibrosis drug FT011 through Phase Ib trials.

bionity.com Tue 10 Feb 2009 Fibrotech Medical Research Commercialisation Fund (MRCF)National Institutes of Health St Vincent's Hospital Melbourne University of Melbourne BBF1 IIF Brandon Capital Uniseed Assoc Prof Darren Kelly

Assoc Prof Darren Kelly

Roles

Coverage

Fibrotech Therapeutics receives investment funding from Brandon Capital Partners, MRCF and Uniseed to develop fibrosis drugs